The largest community of pharma leaders

ImmunSYS, Inc. Adds New Members to Its Board of Directors

FORT LAUDERDALE, Fla.–(BUSINESS WIRE)–#immunotherapy–ImmunSYS, Inc., a clinical stage biotechnology company focused on the development of innovative cancer immunotherapy products, announced today that Joseph C. Maroon, M.D., Charles J. Link, M.D., Jeffery L. Cleland, Ph.D., and Norman D. Schwartz have joined its Board of Directors. ImmunSYS Chairman and CEO, Eamonn Hobbs commented, “We are thrilled to expand the ImmunSYS, Inc. Board with these four exceptional individuals. Their extensive breadth of…..

Recent Articles